Loading...
Prevalence and Determinants of End of Life Chemotherapy Use in Patients with Metastatic Breast Cancer
BACKGROUND: Cessation of chemotherapy in the last few weeks of life could be an important quality of care benchmark. Proportion of metastatic breast cancer patients who receive end of life chemotherapy is not well described. We aimed to determine the prevalence and determinants of end of life chemot...
Na minha lista:
| Udgivet i: | Breast J |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675818/ https://ncbi.nlm.nih.gov/pubmed/28845536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.12905 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|